Moxetumomab Pasudotox-tdfk and Orthoclone OKT 3
Determining the interaction of Moxetumomab Pasudotox-tdfk and Orthoclone OKT 3 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: muromonab-cd3
Brand name:
Synonyms: Orthoclone OKT 3 (Intravenous), Orthoclone OKT3
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Orthovisc
- Moxetumomab Pasudotox-tdfk-Orudis
- Moxetumomab Pasudotox-tdfk-Orudis KT
- Moxetumomab Pasudotox-tdfk-Oruvail
- Moxetumomab Pasudotox-tdfk-Orvaten
- Moxetumomab Pasudotox-tdfk-Os-Cal 500+D
- Orthoclone OKT 3-Moxetumomab pasudotox-tdfk Intravenous
- Orthoclone OKT 3-Moxifloxacin
- Orthoclone OKT 3-Moxifloxacin (Systemic)
- Orthoclone OKT 3-Moxifloxacin Hydrochloride
- Orthoclone OKT 3-Moxifloxacin Injection
- Orthoclone OKT 3-Moxifloxacin Intravenous